Reiterates FY revenue, core EPS guidance (Il Sole 24 Ore Radiocor) - London, 25 Apr - The Anglo-Swedish pharmaceutical group AstraZeneca said that in the first quarter reported earnings per share amounted to 1.41 dollars, up a reported 21% and up 30% at constant exchange rates, and core EPS stood at 2.06 dollars, up 7% at actual exchange rates and 13% at constant currency rates.

Total revenue was 12.679 billion dollars, up a reported 17% and 19% on a currency-neutral basis.

The company reiterated its revenue and core EPS guidance at constant exchange rates.

Total revenue and core EPS are expected to increase by a low double-digit to low teens percentage rate.

AAA-Web

(RADIOCOR) 25-04-24 09:11:36 (0209) 5 NNNN